Posada-Vélez V, Gómez A, Díaz JC, Aristizábal J, Marín J, Velásquez J, Uribe W, Duque M

Language: English
References: 17
Page: 25-29
PDF size: 1700.39 Kb.

ABSTRACT

Kearns-Sayre syndrome (KSS) is a rare cause of complete atrioventricular (AV) block in young patients. This disorder is caused by mitochondrial DNA (mtDNA) deletions, and unlike other mitochondrial diseases, involvement of the cardiac conduction system is frequent. KSS is characterized by the triad of progressive external ophthalmoplegia, pigmentary retinopathy and cardiac conduction system disturbances, with an onset before 20 years of age. We present a case of complete AV block due to this rare condition, which was diagnosed with a muscular biopsy taken at the time of pacemaker implant.

REFERENCES

1. Baritussio A, Ghosh Dastidar A, Frontera A, Ahmed N, De Garate E, Harries I et al. Diagnostic yield of cardiovascular magnetic resonance in young-middle aged patients with high-grade atrio-ventricular block. Int J Cardiol. 2017; 244: 335-339.

2. Kabunga P, Lau AK, Phan K, Puranik R, Liang C, Davis RL et al. Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy. Int J Cardiol. 2015; 181: 303-310.

3. Remes AM, Majamaa-Voltti K, Karppa M, Moilanen JS, Uimonen S, Helander H et al. Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Neurology. 2005; 64 (6): 976-981.

4. Yesil M, Bayata S, Postaci N, Arikan E. Progression of conduction system disease in a paced patient with Kearns-Sayre syndrome. Clin Cardiol. 2009; 32 (6): E65-E67.

5. van Beynum I, Morava E, Taher M, Rodenburg RJ, Karteszi J, Toth K et al. Cardiac arrest in Kearns-Sayre syndrome. JIMD Rep. 2012; 2: 7-10.

6. Ramcharan CR. Heart block, ptosis, and diagnostic funduscopic examination: problems of the heart seen through the eyes. Can J Cardiol. 2018; 34 (5): 690.e1-690.e3.

7. Galetta F, Franzoni F, Mancuso M, Orsucci D, Tocchini L, Papi R et al. Cardiac involvement in chronic progressive external ophthalmoplegia. J Neurol Sci. 2014; 345 (1-2): 189-192.

8. Krishna MR. Kearns sayre syndrome: looking beyond a-v conduction. Indian Pacing Electrophysiol J. 2017; 17 (3): 78-80.

9. Gobu P, Karthikeyan B, Prasath A, Santhosh S, Balachander J. Kearns Sayre syndrome (KSS) - a rare cause for cardiac pacing. Indian Pacing Electrophysiol J. 2011; 10 (12): 547-550.

10. Agrawal H, Ekhomu O, Choi HW, Naheed Z. Natural history of conduction abnormalities in a patient with Kearns-Sayre syndrome. Pediatr Cardiol. 2013; 34 (4): 1044-1047.

11. Young TJ, Shah AK, Lee MH, Hayes DL. Kearns-Sayre syndrome: a case report and review of cardiovascular complications. Pacing Clin Electrophysiol. 2005; 28 (5): 454-457.

12. Karanikis P, Korantzopoulos P, Kountouris E, Dimitroula V, Patsouras D, Pappa E et al. Kearns-Sayre syndrome associated with trifascicular block and QT prolongation. Int J Cardiol. 2005; 101 (1): 147-150.

13. Oginosawa Y, Abe H, Nagatomo T, Mizuki T, Nakashima Y. Sustained polymorphic ventricular tachycardia unassociated with QT prolongation or bradycardia in the Kearns-Sayre syndrome. Pacing Clin Electrophysiol. 2003; 26 (9): 1911-1912.

14. Rashid A, Kim MH. Kearns-Sayre syndrome: association with long QT syndrome? J Cardiovasc Electrophysiol. 2002; 13 (2): 184-185.

15. Imamura T, Sumitomo N, Muraji S, Mori H, Osada Y, Oyanagi T et al. The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles. Int J Cardiol. 2019; 279: 105-111.

16. Pruett RC. Retinitis pigmentosa: clinical observations and correlations. Trans Am Ophthalmol Soc. 1983; 81: 693-735.

17. Kozak I, Oystreck DT, Abu-Amero KK, Nowilaty SR, Alkhalidi H, Elkhamary SM et al. New observations regarding the retinopathy of genetically confirmed Kearns-Sayre syndrome. Retin Cases Brief Rep. 2018; 12 (4): 349-358.